| 000 | 01880 a2200529 4500 | ||
|---|---|---|---|
| 005 | 20250516062639.0 | ||
| 264 | 0 | _c20120618 | |
| 008 | 201206s 0 0 eng d | ||
| 022 | _a1744-6880 | ||
| 024 | 7 |
_a10.1097/FPC.0b013e32834d3e0b _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aDervieux, Thierry | |
| 245 | 0 | 0 |
_aPatterns of interaction between genetic and nongenetic attributes and methotrexate efficacy in rheumatoid arthritis. _h[electronic resource] |
| 260 |
_bPharmacogenetics and genomics _cJan 2012 |
||
| 300 |
_a1-9 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAge Factors |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aArthritis, Rheumatoid _xdrug therapy |
| 650 | 0 | 4 | _aBiomarkers, Pharmacological |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenetic Association Studies |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 |
_aMetabolic Networks and Pathways _xgenetics |
| 650 | 0 | 4 |
_aMethotrexate _xtherapeutic use |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aMultifactor Dimensionality Reduction _xmethods |
| 650 | 0 | 4 |
_aPeptides, Cyclic _ximmunology |
| 650 | 0 | 4 |
_aPhosphoribosylaminoimidazolecarboxamide Formyltransferase _xblood |
| 650 | 0 | 4 |
_aPolymorphism, Single Nucleotide _xgenetics |
| 650 | 0 | 4 |
_aPyrophosphatases _xblood |
| 650 | 0 | 4 |
_aReduced Folate Carrier Protein _xblood |
| 650 | 0 | 4 | _aSex Factors |
| 650 | 0 | 4 | _aInosine Triphosphatase |
| 700 | 1 | _aWessels, Judith A M | |
| 700 | 1 | _aKremer, Joel M | |
| 700 | 1 | _aPadyukov, Leonid | |
| 700 | 1 | _aSeddighzadeh, Maria | |
| 700 | 1 | _aSaevarsdottir, Saedis | |
| 700 | 1 | _avan Vollenhoven, Ronald F | |
| 700 | 1 | _aKlareskog, Lars | |
| 700 | 1 | _aHuizinga, Tom W | |
| 700 | 1 | _aGuchelaar, Henk-Jan | |
| 773 | 0 |
_tPharmacogenetics and genomics _gvol. 22 _gno. 1 _gp. 1-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1097/FPC.0b013e32834d3e0b _zAvailable from publisher's website |
| 999 |
_c21275399 _d21275399 |
||